Addison Capital CO Precigen, Inc. Transaction History

Addison Capital CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.08 - $1.85 $437 - $749	-405 Reduced 3.86%	10,096 $14,000
Q2 2023 Aug 18, 2023	SELL	$0.96 - $1.4 $33 - $49	-35 Reduced 0.33%	10,501 $12,000
Q1 2023 Apr 13, 2023	SELL	$0.88 - $2.19 $39 - $98	-45 Reduced 0.43%	10,536 $11,000
Q4 2022 Jan 09, 2023	SELL	$1.27 - $2.26 $603 - $1,073	-475 Reduced 4.3%	10,581 $16,000
Q3 2021 Oct 12, 2021	SELL	$4.99 - $6.55 $99 - $131	-20 Reduced 0.18%	11,056 $55,000
Q4 2020 Jan 12, 2021	SELL	$3.75 - $10.56 $5,325 - $14,995	-1,420 Reduced 11.36%	11,076 $113,000
Q3 2020 Oct 13, 2020	SELL	$3.5 - $6.2 $87 - $155	-25 Reduced 0.2%	12,496 $44,000
Q1 2020 Apr 13, 2020	BUY	$1.46 - $7.19 $18,280 - $90,025	12,521 New	12,521 $43,000

141

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $231M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Addison Capital CO, based on Form 13F filings with the SEC.

Stay updated on Addison Capital CO with notifications on news.